Business
Press Release May 31 2023
Laurus Labs Limited has informed the Exchange regarding a press release dated May 31, 2023, titled "Laurus Labs further invests in Cell and Gene therapy company ImmunoACT; to hold 33.86% stake post- completion of the transaction".
About this update from Laurus Labs Ltd.
[{"type":"text","content":" Laurus Labs Limited has informed the Exchange regarding a press release dated May 31, 2023, titled \"Laurus Labs further invests in Cell and Gene therapy company ImmunoACT; to hold 33.86% stake post- completion of the transaction\". View Attachment","length":411,"tagName":"div"}]